The use of sevoflurane in acute intermittent porphyria
โ Scribed by P. R. Evans; S. Graham; C. M. Kumar
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 584 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0003-2409
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The porphyrias are a group of disorders caused by deficiencies in the activities of the enzymes of the heme biosynthetic pathway. As a result, abnormally elevated levels of porphyrins and/or their precursors, e.g. delta-aminolevulinic acid and porphobilinogen are produced in excess, accumulate in ti
Acute intermittent porphyria (AIP) is a dominantly inherited metabolic disease caused by a partial deficiency of the third enzyme, porphobilinogen deaminase (PBGD), in the heme biosynthetic pathway. AIP has been divided into two subtypes according to the ratio of enzyme polypeptide concentration and